Clinical Trial Update: A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of VAL401 in locally advanced or metastatic non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• VAL401

Snippet

Sponsor: ValiSeek Limited | Conditions: Carcinoma, Non-Small-Cell Lung, Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-10-15